Literature DB >> 16674948

The structure of PknB in complex with mitoxantrone, an ATP-competitive inhibitor, suggests a mode of protein kinase regulation in mycobacteria.

Annemarie Wehenkel1, Pablo Fernandez, Marco Bellinzoni, Vincent Catherinot, Nathalie Barilone, Gilles Labesse, Mary Jackson, Pedro M Alzari.   

Abstract

Mycobacterium tuberculosis PknB is an essential receptor-like protein kinase involved in cell growth control. Here, we demonstrate that mitoxantrone, an anthraquinone derivative used in cancer therapy, is a PknB inhibitor capable of preventing mycobacterial growth. The structure of the complex reveals that mitoxantrone partially occupies the adenine-binding pocket in PknB, providing a framework for the design of compounds with potential therapeutic applications. PknB crystallizes as a 'back-to-back' homodimer identical to those observed in other structures of PknB in complex with ATP analogs. This organization resembles that of the RNA-dependent protein kinase PKR, suggesting a mechanism for kinase activation in mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16674948     DOI: 10.1016/j.febslet.2006.04.046

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  33 in total

1.  Auto-activation mechanism of the Mycobacterium tuberculosis PknB receptor Ser/Thr kinase.

Authors:  Carl Mieczkowski; Anthony T Iavarone; Tom Alber
Journal:  EMBO J       Date:  2008-11-13       Impact factor: 11.598

2.  Evolution of protein binding modes in homooligomers.

Authors:  Judith E Dayhoff; Benjamin A Shoemaker; Stephen H Bryant; Anna R Panchenko
Journal:  J Mol Biol       Date:  2009-10-30       Impact factor: 5.469

Review 3.  Do Shoot the Messenger: PASTA Kinases as Virulence Determinants and Antibiotic Targets.

Authors:  Daniel A Pensinger; Adam J Schaenzer; John-Demian Sauer
Journal:  Trends Microbiol       Date:  2017-07-19       Impact factor: 17.079

4.  Mycobacterium tuberculosis serine/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitors.

Authors:  Julio Caballero; Alejandro Morales-Bayuelo; Carlos Navarro-Retamal
Journal:  J Comput Aided Mol Des       Date:  2018-10-26       Impact factor: 3.686

5.  NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G.

Authors:  Sohini Chakraborti; Neha Khare; Sumana Das; Saqib Kidwai; Rania Bouzeyen; Tannu Priya Gosain; Assirbad Behura; Chhuttan Lal Meena; Rohan Dhiman; Makram Essafi; Avinash Bajaj; Deepak Kumar Saini; Narayanaswamy Srinivasan; Dinesh Mahajan; Ramandeep Singh
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

6.  Phosphorylation and ATP-binding induced conformational changes in the PrkC, Ser/Thr kinase from B. subtilis.

Authors:  Paweł Gruszczyński; Michał Obuchowski; Rajmund Kaźmierkiewicz
Journal:  J Comput Aided Mol Des       Date:  2010-06-19       Impact factor: 3.686

7.  Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.

Authors:  Andrey E Shchekotikhin; Lyubov G Dezhenkova; Vladimir B Tsvetkov; Yuri N Luzikov; Yulia L Volodina; Victor V Tatarskiy; Anastasia A Kalinina; Michael I Treshalin; Helen M Treshalina; Vladimir I Romanenko; Dmitry N Kaluzhny; Michael Kubbutat; Dominique Schols; Yves Pommier; Alexander A Shtil; Maria N Preobrazhenskaya
Journal:  Eur J Med Chem       Date:  2016-02-04       Impact factor: 6.514

Review 8.  Mycobacterium tuberculosis Serine/Threonine Protein Kinases.

Authors:  Sladjana Prisic; Robert N Husson
Journal:  Microbiol Spectr       Date:  2014-10

9.  Asymmetric enzymatic glycosylation of mitoxantrone.

Authors:  Maoquan Zhou; Jon S Thorson
Journal:  Org Lett       Date:  2011-04-29       Impact factor: 6.005

10.  In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth.

Authors:  Nathan Wlodarchak; Nathan Teachout; Jeffrey Beczkiewicz; Rebecca Procknow; Adam J Schaenzer; Kenneth Satyshur; Martin Pavelka; William Zuercher; David Drewry; John-Demian Sauer; Rob Striker
Journal:  Mol Pharm       Date:  2018-10-18       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.